Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer

  • Charles N. Landen
  • , Chunhua Lu
  • , Liz Y. Han
  • , Karen T. Coffman
  • , Elizabeth Bruckheimer
  • , Jyotsnabaran Halder
  • , Lingegowda S. Mangala
  • , William M. Merritt
  • , Yvonne G. Lin
  • , Changhou Gao
  • , Rosemarie Schmandt
  • , Aparna A. Kamat
  • , Yang Li
  • , Premal Thaker
  • , David M. Gershenson
  • , Nila U. Parikh
  • , Gary E. Gallick
  • , Michael S. Kinch
  • , Anil K. Sood

Research output: Contribution to journalArticlepeer-review

118 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science